<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10-vaccines-08-00142">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gonzalez</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Guillen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gallardo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Díaz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>De La Rosa</surname>
    <given-names>J.V.</given-names>
   </name>
   <name>
    <surname>Hernández</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Casanova-Acebes</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lopez</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Tabraue</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Beceiro</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The nuclear receptor LXRα controls the functional specialization of splenic macrophages</article-title>
  <source>Nat. Immunol.</source>
  <year>2013</year>
  <volume>14</volume>
  <fpage>831</fpage>
  <lpage>839</lpage>
  <pub-id pub-id-type="doi">10.1038/ni.2622</pub-id>
  <pub-id pub-id-type="pmid">23770640</pub-id>
 </element-citation>
</ref>
